214 related articles for article (PubMed ID: 16285013)
1. Antibody-mediated signaling through PD-1 costimulates T cells and enhances CD28-dependent proliferation.
del Rio ML; Penuelas-Rivas G; Dominguez-Perles R; Ramirez P; Parrilla P; Rodriguez-Barbosa JI
Eur J Immunol; 2005 Dec; 35(12):3545-60. PubMed ID: 16285013
[TBL] [Abstract][Full Text] [Related]
2. CD28-independent costimulation of T cells by OX40 ligand and CD70 on activated B cells.
Akiba H; Oshima H; Takeda K; Atsuta M; Nakano H; Nakajima A; Nohara C; Yagita H; Okumura K
J Immunol; 1999 Jun; 162(12):7058-66. PubMed ID: 10358148
[TBL] [Abstract][Full Text] [Related]
3. Programmed cell death 1 (PD-1) and its ligand PD-L1 are required for allograft tolerance.
Wang L; Han R; Hancock WW
Eur J Immunol; 2007 Oct; 37(10):2983-90. PubMed ID: 17899549
[TBL] [Abstract][Full Text] [Related]
4. Involvement of the programmed death-1/programmed death-1 ligand pathway in CD4+CD25+ regulatory T-cell activity to suppress alloimmune responses.
Kitazawa Y; Fujino M; Wang Q; Kimura H; Azuma M; Kubo M; Abe R; Li XK
Transplantation; 2007 Mar; 83(6):774-82. PubMed ID: 17414712
[TBL] [Abstract][Full Text] [Related]
5. Porcine PD-L1: cloning, characterization, and implications during xenotransplantation.
Jeon DH; Oh K; Oh BC; Nam DH; Kim CH; Park HB; Cho J; Lee JR; Lee DS; Lee G
Xenotransplantation; 2007 May; 14(3):236-42. PubMed ID: 17489864
[TBL] [Abstract][Full Text] [Related]
6. Role of the programmed Death-1 pathway in the suppressive activity of alternatively activated macrophages in experimental cysticercosis.
Terrazas LI; Montero D; Terrazas CA; Reyes JL; RodrÃguez-Sosa M
Int J Parasitol; 2005 Nov; 35(13):1349-58. PubMed ID: 16126211
[TBL] [Abstract][Full Text] [Related]
7. Stimulating PD-1-negative signals concurrent with blocking CD154 co-stimulation induces long-term islet allograft survival.
Gao W; Demirci G; Strom TB; Li XC
Transplantation; 2003 Sep; 76(6):994-9. PubMed ID: 14508368
[TBL] [Abstract][Full Text] [Related]
8. CD4-mediated signals induce T cell dysfunction in vivo.
Chirmule N; Avots A; LakshmiTamma SM; Pahwa S; Serfling E
J Immunol; 1999 Jul; 163(2):644-9. PubMed ID: 10395653
[TBL] [Abstract][Full Text] [Related]
9. Differential regulatory signals delivered by antibody binding to the CD28 (Tp44) molecule during the activation of human T lymphocytes.
Damle NK; Doyle LV; Grosmaire LS; Ledbetter JA
J Immunol; 1988 Mar; 140(6):1753-61. PubMed ID: 2964482
[TBL] [Abstract][Full Text] [Related]
10. Blockade of programmed death-1 in young (New Zealand black x New Zealand white)F1 mice promotes the activity of suppressive CD8+ T cells that protect from lupus-like disease.
Wong M; La Cava A; Singh RP; Hahn BH
J Immunol; 2010 Dec; 185(11):6563-71. PubMed ID: 21041733
[TBL] [Abstract][Full Text] [Related]
11. Dual control of antitumor CD8 T cells through the programmed death-1/programmed death-ligand 1 pathway and immunosuppressive CD4 T cells: regulation and counterregulation.
Currie AJ; Prosser A; McDonnell A; Cleaver AL; Robinson BW; Freeman GJ; van der Most RG
J Immunol; 2009 Dec; 183(12):7898-908. PubMed ID: 20007574
[TBL] [Abstract][Full Text] [Related]
12. CD44 contributes to T cell activation.
Huet S; Groux H; Caillou B; Valentin H; Prieur AM; Bernard A
J Immunol; 1989 Aug; 143(3):798-801. PubMed ID: 2568380
[TBL] [Abstract][Full Text] [Related]
13. PD-L2 is a second ligand for PD-1 and inhibits T cell activation.
Latchman Y; Wood CR; Chernova T; Chaudhary D; Borde M; Chernova I; Iwai Y; Long AJ; Brown JA; Nunes R; Greenfield EA; Bourque K; Boussiotis VA; Carter LL; Carreno BM; Malenkovich N; Nishimura H; Okazaki T; Honjo T; Sharpe AH; Freeman GJ
Nat Immunol; 2001 Mar; 2(3):261-8. PubMed ID: 11224527
[TBL] [Abstract][Full Text] [Related]
14. Impaired interleukin-2 synthesis and T cell proliferation following antibody-mediated CD3 and CD2 or CD28 cross-linking in trans: evidence that T cell activation requires the engagement of costimulatory molecules within the immunological synapse.
Watson CL; Furlong SJ; Hoskin DW
Immunol Invest; 2008; 37(1):63-78. PubMed ID: 18214800
[TBL] [Abstract][Full Text] [Related]
15. CD4+PD-1+ T cells acting as regulatory cells during the induction of anterior chamber-associated immune deviation.
Meng Q; Yang P; Li B; Zhou H; Huang X; Zhu L; Ren Y; Kijlstra A
Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4444-52. PubMed ID: 17003438
[TBL] [Abstract][Full Text] [Related]
16. Blockade of the interaction between PD-1 and PD-L1 accelerates graft arterial disease in cardiac allografts.
Koga N; Suzuki J; Kosuge H; Haraguchi G; Onai Y; Futamatsu H; Maejima Y; Gotoh R; Saiki H; Tsushima F; Azuma M; Isobe M
Arterioscler Thromb Vasc Biol; 2004 Nov; 24(11):2057-62. PubMed ID: 15374847
[TBL] [Abstract][Full Text] [Related]
17. A monoclonal antibody reactive with a 40-kDa molecule on fetal thymocytes and tumor cells blocks proliferation and stimulates aggregation and apoptosis.
Fernandes DM; Baird AM; Berg LJ; Rock KL
J Immunol; 1999 Aug; 163(3):1306-14. PubMed ID: 10415028
[TBL] [Abstract][Full Text] [Related]
18. Internalization of phosphatidylinositol-anchored lymphocyte proteins. I. Documentation and potential significance for T cell stimulation.
Bamezai A; Goldmacher V; Reiser H; Rock KL
J Immunol; 1989 Nov; 143(10):3107-16. PubMed ID: 2572642
[TBL] [Abstract][Full Text] [Related]
19. Expression of CD30 ligand (CD153) on murine activated T cells.
Shimozato O; Takeda K; Yagita H; Okumura K
Biochem Biophys Res Commun; 1999 Mar; 256(3):519-26. PubMed ID: 10080930
[TBL] [Abstract][Full Text] [Related]
20. Regulation of murine chronic colitis by CD4+CD25- programmed death-1+ T cells.
Totsuka T; Kanai T; Makita S; Fujii R; Nemoto Y; Oshima S; Okamoto R; Koyanagi A; Akiba H; Okumura K; Yagita H; Watanabe M
Eur J Immunol; 2005 Jun; 35(6):1773-85. PubMed ID: 15902682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]